DE69408579D1 - Asserlösliche pharmazeutische zusammensetzungen, die östronderivate und kalziumsalze enthalten - Google Patents

Asserlösliche pharmazeutische zusammensetzungen, die östronderivate und kalziumsalze enthalten

Info

Publication number
DE69408579D1
DE69408579D1 DE69408579T DE69408579T DE69408579D1 DE 69408579 D1 DE69408579 D1 DE 69408579D1 DE 69408579 T DE69408579 T DE 69408579T DE 69408579 T DE69408579 T DE 69408579T DE 69408579 D1 DE69408579 D1 DE 69408579D1
Authority
DE
Germany
Prior art keywords
pct
water
pharmaceutical compositions
compositions containing
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69408579T
Other languages
English (en)
Other versions
DE69408579T2 (de
Inventor
Romano Deghenghi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69408579D1 publication Critical patent/DE69408579D1/de
Application granted granted Critical
Publication of DE69408579T2 publication Critical patent/DE69408579T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DE69408579T 1993-09-17 1994-07-26 Asserlösliche pharmazeutische zusammensetzungen, die östronderivate und kalziumsalze enthalten Expired - Fee Related DE69408579T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI932014A IT1270831B (it) 1993-09-17 1993-09-17 Composizioni farmaceutiche orali effervescenti contenenti estrone
PCT/EP1994/002465 WO1995007701A1 (en) 1993-09-17 1994-07-26 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt

Publications (2)

Publication Number Publication Date
DE69408579D1 true DE69408579D1 (de) 1998-03-26
DE69408579T2 DE69408579T2 (de) 1998-06-18

Family

ID=11366921

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69408579T Expired - Fee Related DE69408579T2 (de) 1993-09-17 1994-07-26 Asserlösliche pharmazeutische zusammensetzungen, die östronderivate und kalziumsalze enthalten

Country Status (12)

Country Link
US (1) US5720977A (de)
EP (1) EP0719148B1 (de)
JP (1) JPH09502709A (de)
KR (1) KR100314338B1 (de)
AT (1) ATE163265T1 (de)
AU (1) AU7532994A (de)
CA (1) CA2171829A1 (de)
DE (1) DE69408579T2 (de)
ES (1) ES2112555T3 (de)
IL (1) IL110471A (de)
IT (1) IT1270831B (de)
WO (1) WO1995007701A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
US6726922B1 (en) 1999-06-28 2004-04-27 Minu, L.L.C. Process and composition for temporarily suppressing pain
WO2001018044A2 (en) * 1999-09-08 2001-03-15 Immunex Corporation Use of semaphorin for modulation of cellular efflux
DE60114467T2 (de) * 2000-12-14 2006-07-20 Ortho-Mcneil Pharmaceutical, Inc. Zubereitungen enthaltend ein steroidhormon und ein stabilisierungsmittel in nicht-kristalliner form
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
US6630166B1 (en) 2001-02-12 2003-10-07 Watson Pharmaceuticals, Inc. Compositions for conjugated estrogens and associated methods
US20030068356A1 (en) 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
CA2601773A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
EP1971325A2 (de) * 2005-12-27 2008-09-24 Duramed Pharmaceuticals, Inc. Konjugierte östrogen-zusammensetzungen, applikatoren, kits und verfahren zur ihrer herstellung und verwendung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004651A (en) * 1989-01-24 1991-04-02 Abbott Laboratories Stabilizing system for solid dosage forms

Also Published As

Publication number Publication date
IL110471A (en) 1998-10-30
CA2171829A1 (en) 1995-03-23
JPH09502709A (ja) 1997-03-18
US5720977A (en) 1998-02-24
AU7532994A (en) 1995-04-03
ATE163265T1 (de) 1998-03-15
EP0719148A1 (de) 1996-07-03
ES2112555T3 (es) 1998-04-01
IT1270831B (it) 1997-05-13
EP0719148B1 (de) 1998-02-18
IL110471A0 (en) 1994-10-21
DE69408579T2 (de) 1998-06-18
ITMI932014A1 (it) 1995-03-17
KR100314338B1 (ko) 2002-02-28
WO1995007701A1 (en) 1995-03-23
ITMI932014A0 (it) 1993-09-17

Similar Documents

Publication Publication Date Title
TW341514B (en) Aqueous topical pharmaceutical compositions useful for exfoliation and prevention or treatment of acne
EA199900075A1 (ru) Гранулят для получения быстрораспадающихся и быстрорастворяющихся композиций, содержащих большое количество лекарственного средства
TR200101261T2 (tr) Uzun süreli salınımlı ranolazin formülasyonları.
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
ATE158504T1 (de) Brausemischungen enthaltend ibuprofen und verfahren
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
DE69832710D1 (de) Nicht-irritierende zusammensetzung zur behandlung des aknes und andere hautzustände
KR960700061A (ko) 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence)
DE69408579D1 (de) Asserlösliche pharmazeutische zusammensetzungen, die östronderivate und kalziumsalze enthalten
BRPI0410116A (pt) tablete de cuidado oral
ATE73656T1 (de) Entzuendungshemmendes ibuprofen enthaltendes arzneimittel, das in waessriger loesung keinen bitteren geschmack, keine reizung des kehlkopfes und keine intestinale toxizitaet aufweist.
UY24308A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol, para administracion oral
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
IL109534A0 (en) Pour-on formulations containing polymeric material, glycols and glycerides and a process for their preparation
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
UA42733C2 (uk) Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
KR890006236A (ko) 피페리디노 알칸올-충혈제거제 조합을 위한 약제학적 조성물
AP9801235A0 (en) Erythromycin derivatives.
YU81101A (sh) Polimorfni oblici kristalnog citrata azabiciklo (2,2,2) oktan-3-amina i njihovih farmaceutskih kompozicija
AR008764A1 (es) Sales hidratadas de n,n'-diacetilcistina, proceso para su preparacion, y composiciones terapeuticas que comprenden a dichas sales como ingredienteactivo.
ATE77238T1 (de) Primycin-loesungen.
NZ509593A (en) Compressed compositions comprising clarified xanthan gum
KR970009798A (ko) 포유동물에서의 유리 라디칼 손상을 감소시키기 위해 철 킬레이트화 화합물을 사용하는 방법
IT1255268B (it) Composizione farmaceutica ad attivita' antitosse

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee